课题基金 / 基金详情

Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer

Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer
非编码 RNA 作为前列腺癌的预后和诊断标志物
批准号:
10014478
负责人:
Stefan Ambs
金额:
$9.5万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Stefan Ambs的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this project, we have been exploring the function of two microRNAs, miR-484 and mir-769. In our previous studies, we identified mir-484 as being associated with extraprostatic extension and further analyses revealed that miR-484 significantly associates with reduced recurrence-free survival. Additional experiments showed that miR-484 expression increases migration of prostate cancer cells. There is not much known about the function of this microRNA. It is a regulator of mitochondrial biogenesis. A pathway analysis of TargetScan-predicted target genes indicated that this microRNA may regulate metabolism. These predicted functions were investigated. Furthermore, we studied the function of mir-769 and its involvement in migration and invasion of human prostate cancer cells. Studies of these two microRNAs have been completed and the project was discontinued in 2019. A manuscript describing the function of miR-484 has been submitted.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Molecular Profile of Prostate Tumors in African-American Men
Novel Markers for Disease Outcome in Breast Cancer
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer
海外基金